LTA Frequently Asked Questions Document Now Available!
Our much-anticipated Frequently Asked Questions Document is now available! I encourage you to read the entire document, even if you are mainly interested in only a few of the questions,
Our much-anticipated Frequently Asked Questions Document is now available! I encourage you to read the entire document, even if you are mainly interested in only a few of the questions,
Below is the compiled list of all questions submitted thus far. If you have a question that you do not see on this list, please send it to us by
Never has it been more clear how much can be accomplished when we come together, raise our collective voices, and don’t give up! Passage of the Lymphedema Treatment Act marks
Today, the House passed the year-end omnibus legislative package that cleared the Senate yesterday and included the Lymphedema Treatment Act, which means our bill has officially been passed by Congress!
Today, the Senate passed the year-end omnibus legislative package, which contains the Lymphedema Treatment Act, by a vote of 68-29, with three Senators not voting. Tomorrow/Friday morning, the House will
Voting could start on the year-end package that includes the Lymphedema Treatment Act as early as tomorrow/Thursday! If you haven’t called your members of Congress yet and urged them to
As reported earlier today, the Lymphedema Treatment Act has been included in the year-end legislative package! Both chambers will be voting on this package later this week. PLEASE call your
We did it — the Lymphedema Treatment Act has been included in the year-end legislative package!!!! The contents of the package were finally released overnight and will be voted on
A huge thank-you to everyone who has made their phone calls! If you haven’t yet, it’s not too late. And if you tried but had trouble getting through or couldn’t
Join our email list to learn about
changes to insurance coverage, advocacy actions,
new educational materials and more.
Subscribers receive approximately
one email per week with information
from both of our organizations.

